A new study estimates over 250,000 new cancer cases and 87,900 cancer-related deaths in Canada for 2026. Lung, breast, prostate, and colorectal cancers are projected to comprise 47 percent of all new diagnoses.
The aging and growing Canadian population contributes to a year-over-year increase in cancer diagnoses and deaths, impacting society economically.
Among men, prostate cancer is expected to be the most common diagnosis (23 percent), followed by lung (12 percent), colorectal (11 percent), and bladder (8 percent). For women, breast cancer leads at 26 percent, with lung (14 percent), colorectal (9 percent), and uterine (7 percent) cancers also common.
Lung cancer is anticipated to cause one in five cancer-related deaths in 2026. The five leading causes of cancer death are lung, colorectal, pancreatic, breast, and prostate cancers, accounting for over half of all cancer fatalities.
Separately, research indicates that individuals who survive cancer as adolescents and young adults face a doubled risk of developing a second cancer. Experts cite radiation, chemotherapy, and hormone therapies as potential causes, alongside genetic predispositions. Advances in treatments aim to reduce long-term carcinogenic effects.
Cervical cancer is identified as Canada's fastest-rising form, with efforts underway to eliminate it as a public health problem by 2040. Additionally, recommendations are being made to lower the routine screening age for colorectal cancer to 45 for average-risk individuals, a step already adopted by Prince Edward Island.
